随着老龄化进程的加快和人民生活水平的提高,我国前列腺增生症(BPH)的发病明显增加,目前已和欧美国家的发病率相仿,BPH已成为我国泌尿外科最常见的疾病。药物治疗作为首选的治疗方法仅对轻度和中度增生病人有效,而对重度增生病人,特别是剩余尿较多的病人,仍需外科的干预才能解除梗阻。但前列腺增生发生在老年人,他们常常伴有其他严重疾病,难于耐受开放手术所带来的创伤。因此,各种微创的经尿道前列腺增生腔内治疗,受到泌尿外科医生的极大重视,在BPH的外科干预治疗 With the accelerated aging process and the improvement of people’s living standards, the incidence of benign prostatic hyperplasia (BPH) in our country has obviously increased. At present, the incidence of BPH has been similar to that in European and American countries. BPH has become the most common urological disease in our country. Medication as the preferred treatment is effective only in patients with mild and moderate hyperplasia, while patients with severe hyperplasia, especially those with high residual urine, require surgical intervention to relieve the obstruction. However, benign prostatic hyperplasia occurs in the elderly, they are often accompanied by other serious diseases, difficult to tolerate the wounds caused by open surgery. Therefore, a variety of minimally invasive transurethral and benign prostatic hyperplasia endovascular treatment by urologists great attention in the surgical intervention of BPH